Introduction {#s1}
============

Bone remodeling is a constant natural mechanism involving the coordinated effort of two major cell populations: osteoblasts and osteoclasts. Osteoblasts form bone matrix and regulate the bone-resorbing activity of osteoclasts. Originally arising from pluripotent mesenchymal stem cells, bone-forming cells differentiate progressively in several stages and become osteoblasts that, after their terminal differentiation, are fully mature (Aubin, [@B3]). Each step of the osteoblastic lineage plays a specific role. For example, synthesis of extracellular matrix is mainly carried out by pre-osteoblasts and immature osteoblasts whereas mature osteoblasts are more involved in the mineralization of the extracellular matrix (Komori, [@B20]). Several markers of osteoblast development are expressed during their maturation. These include alkaline phosphatase, type I collagen and osteopontin, which are important for controlling bone matrix deposition and mineralization. Mature osteoblasts also produce regulators of matrix mineralization at the end of maturation such as osteocalcin and bone sialoprotein (Marie, [@B26]). In *in vitro* culture models, osteoblast differentiation, and maturation are mainly performed in a specific osteogenic medium (OM) containing ascorbic acid, β-glycerophosphate, and dexamethasone (Brauer et al., [@B7]).

There is growing evidence that osteoblasts may have additional functions with regard to cytokine production in diseases such as rheumatoid arthritis and osteoarthritis (Lisignoli et al., [@B23]). Osteomyelitis is a damaging bone infection that can lead to sequelae and death if left untreated and mostly results from hematogenous spreading from distant infected tissues during childhood. In adulthood, surgical procedures are increasingly responsible for direct contamination of bone tissues, especially when medical devices are used (Montanaro et al., [@B30]). *Staphylococcus aureus*, (*S. aureus)*, a gram-positive bacterium, is one of the most incriminated pathogens in osteomyelitis and implant-associated infections (Lowy, [@B25]). In the past, *S. aureus* was mostly considered to be an extracellular pyogenic pathogen but it is now known to be internalized and to persist in non-professional phagocytes while being protected from the immune system (Löffler et al., [@B24]). The internalization of *S. aureus* has been mainly observed in endothelial cells, lung epithelial cells, mesenchymal stem cells, and osteoblasts (Ogawa et al., [@B31]; Hudson et al., [@B14]; Jarry and Cheung, [@B15]; Josse et al., [@B18]). Moreover, osteocytes, which are the last step in osteoblast differentiation, are also able to internalize *S. aureus* (Reilly et al., [@B34]). *S. aureus* osteomyelitis therefore develops very often from acute infection to a state of chronicity despite the use of antimicrobial treatments. This leads to a wide spectrum of events ranging from damage to single cells to a delay in bone regeneration or excessive inflammatory response. Three major types of harmful responses for bone tissue can be triggered (reviewed in Josse et al., [@B17]). First, *S. aureus*-infected osteoblasts die through the activation of both apoptosis and necrosis. Second, *S. aureus* can induce the expression and the release of cytokines and chemokines. Third, among these cytokines, *S. aureus* can promote the activation and formation of osteoclasts notably via an increase in RANKL production by osteoblasts. Together, all these events can result in a massive inflammatory bone loss (Lew and Waldvogel, [@B22]). However, to date, the influence of the maturation stage of osteoblasts in such a setting has remained elusive.

The aim of this study was therefore to investigate whether the degree of maturation of human primary bone-forming cells (HPBCs) can impact their interaction with *S. aureus*. We cultured HPBCs in a standard growth medium to maintain their heterogeneity and in a dexamethasone-free osteogenic growth medium to obtain a population mostly composed of cells expressing maturation markers. Moreover, two models of HPBC interaction with live *S. aureus* were used in order to mimic the onset of early and persistent infection. Taken together, our data show that dexamethasone-free OM can lead to the maturation of HPBCs. Moreover, we demonstrate that the internalization and intracellular survival of *S. aureus* and *S. aureus*-related cell death are not influenced by the degree of maturation of HPBCs. Investigation of their cytokine and chemokine expression revealed some influence of their degree of maturation but no variation in relative protein release was observed.

Materials and methods {#s2}
=====================

Bacteria culture
----------------

*S. aureus* 8325-4, a wild-type laboratory strain (prophage-free NCTC 8325), was a generous gift from T.J. Foster (Department of Microbiology, Trinity College, Dublin, Ireland). Bacteria were maintained at −80°C and streaked onto trypticase soy broth (TSB) agar plates (BioMérieux) to obtain single colonies. After overnight growth in TSB medium at 37°C, *S. aureus* was re-suspended in TSB at a starting OD (620 nm) of 0.1 and cultured at 37°C up to an exponential growth phase (OD~620~ = 0.4--0.6). The bacteria were then washed and resuspended in sterile Dulbecco\'s Phosphate Buffered Saline (DPBS, Gibco) for the interaction experiments described below.

Cell culture and maturation
---------------------------

HPBCs used in this study were obtained from patients\' femoral bone explants and prepared as described previously (Braux et al., [@B8]; Brun et al., [@B9]). Bone explants were obtained from the femoral heads of 11 patients in the orthopedic and traumatology department of the University Hospital Center in Reims, France. Samples were collected after written informed consent had been given by the donors following the guidelines approved by the University Hospital Center institutional review board. The explants were cut into small pieces, washed in DPBS four times for 5 min, digested in a solution of 0.5% trypsin, 5.3 mM EDTA (Life Technologies), and then in type II collagenase (1.4 mg.mL^−1^, Sigma Aldrich). The fragments obtained were thereafter placed in 25 cm^2^ culture flasks containing Dulbecco\'s Modified Eagle Medium (DMEM, Gibco) supplemented with 20% FCS (Dutscher) and 1% antibiotic solution PenStrep^®^ (Gibco), then incubated at 37°C in a 5% CO~2~ humidified atmosphere. Cells were amplified for four passages and then divided into two cell populations. The first population was cultured in the previous medium containing only 10% FCS and considered as standard medium (SM) and the second one was cultured in SM medium enriched with ascorbic acid (50 μM, Gibco) and β-glycerophosphate (10 μM, Sigma Aldrich), hereafter named osteogenic medium (OM). To avoid the anti-inflammatory effects of dexamethasone regularly used in OM (Wright and Friedland, [@B44]), ours was dexamethasone-free. Upon the fifth passage, cells were seeded at a density of 1 × 10^4^ cells per cm^2^ in 24-well culture plates (BD Falcon) and cultured up to 28 days in each medium to assess the osteogenic differentiation model. For fluorescent staining, cells were seeded on glass coverslips or for scanning electron microscopy on Thermanox^®^ coverslips (Thermo Scientific). LPS 0111:B4 (1 μg.mL^−1^) (Sigma Aldrich) was used to confirm the cells\' ability to respond to a pro-inflammatory stimulus.

Set of interaction between HPBCs and *S. aureus*
------------------------------------------------

Infection experiments were performed on both cell populations after 14 days of culture of HPBCs. Confluent cell cultures were washed with DPBS and incubated overnight with 1 mL of respective media without antibiotics. The following day, cells were washed with DPBS, SM, or OM without antibiotics (1 mL/well) was renewed and bacteria were added. Cell count per well was determined to optimize the multiplicity of infection (MOI) in order to obtain 10:1 and 30:1 (*S. aureus*: cell). Interactions were performed according to two models defined as acute and persistent infections.

The acute infection model, representing the outbreak of an infection, was performed as previously described (Josse et al., [@B18]). It allows extracellular and intracellular bacteria to interact with cells. Briefly, infections were performed between bacteria and HPBCs for 1, 3, 6, and 9 h at MOI of 10:1 and 30:1 (*S. aureus*/cell).

The model of persistent infection adapted from Wright and Friedland ([@B43]) is classically used to investigate the impact of chronic infection in osteoblasts. After 1 h of interaction between bacteria and cells (MOI of 10:1 and 30:1), co-cultures were washed twice with DPBS and then incubated with the appropriate growth medium containing 100 μg.mL^−1^ gentamycin for additional incubations to reach 9, 24, and 48 h of interaction. Gentamycin is an antibiotic that does not diffuse inside HPBCs in 48 h and so is active only on extracellular bacteria (Wilson et al., [@B42]). This model makes it possible to examine the impact of solely intracellular bacteria.

Intracellular counting
----------------------

At the end of each interaction time in the model of acute infection, co-cultures were washed three times with DPBS and incubated 1 h with growth medium containing 100 μg.mL^−1^ gentamycin at 37°C in a 5% CO~2~ humidified atmosphere. Then, cells were washed three times with DPBS and 0.1% Triton X-100 solution was added to each well to harvest intracellular bacteria. Appropriated dilutions of the lysates were plated in triplicate on TSA plates for determination of the recovered colony forming units (CFU) after incubation for 18 h at 37°C.

For the model of persistent infection, co-cultures were processed in the same way and washed three times with DPBS before the numbers of intracellular bacteria were determined as described above.

Alkaline phosphatase activity
-----------------------------

Alkaline phosphatase activity was determined by using the precipitating substrate BCIP^®^/NBT (SigmaFast™, Sigma). At various time intervals (7, 14, 21, and 28 days), cell cultures were rinsed twice with DPBS and fixed with 4% paraformaldehyde in DPBS. Then, wells were rinsed twice with DPBS and incubated for 10 min with BCIP^®^/NBT. Thereafter, wells were rinsed twice with DPBS and dried in order to reveal by imaging the precipitation in the entire wells (Scanner Epson Perfection 1660 Photo).

Alizarin red staining
---------------------

At 7, 14, 21, and 28 days, cells were rinsed twice with DPBS and fixed with 4% paraformaldehyde in DPBS. Then, wells were rinsed twice with DPBS and distilled water. Cell cultures were incubated for 10 min with alizarin red staining solution (Sigma). At the end of the incubation period, wells were rinsed twice with DPBS and dried in order to image the entire wells (Scanner Epson Perfection 1660 Photo).

Type I collagen and osteocalcin immunofluorescent staining
----------------------------------------------------------

Twenty-one-day cell cultures were rinsed twice with DPBS and then fixed with 4% paraformaldehyde (Agar Scientific LTD) in DPBS containing 0.1% Triton X-100 (Prolabo) for 5 min at room temperature. After DPBS rinsing and 3% bovine serum albumin (BSA, Sigma Aldrich) saturation for 1 h, samples were incubated for 1 h with anti-human type I collagen antibodies (clone H-197, Santa-Cruz) or with anti-human osteocalcin antibodies (clone 190125, R&D Systems) (diluted at 1/400 and 1/50 respectively). After another BSA saturation step, samples were incubated with biotinylated horse anti-rabbit or goat anti-mouse secondary antibodies (diluted at 1/50, Vector) for 30 min, rinsed in DPBS and incubated in a solution of streptavidine-Alexafluor^®^488 (diluted at 1/200, Molecular Probes) for 30 min and rinsed in DPBS. After rinsing with dH~2~O, cell nuclei were counterstained for 5 min with DAPI (Invitrogen). These cells were mounted on glass coverslips (Fluorescent Mounting Medium Dako) and then visualized with a Zeiss Axiovert 200 M inverted microscope (Carl Zeiss).

LDH measurement
---------------

Lactate dehydrogenase (LDH) activity in cell supernatant is relevant for evaluating cell membrane damage. At the end of each time period for both models of infection, LDH activity was assessed on conditioned cell culture supernatants (Cytotoxicity detection kit plus^®^, Roche Diagnostics) following the manufacturer\'s instructions. Absorbance was read at 592 nm with correction of non-specific background at 700 nm.

Enzyme-linked immunosorbent assay
---------------------------------

Pro-inflammatory cytokines (IL-1β and IL-6), chemokines (CCL2, CXCL1, and CXCL8), and OPG concentrations in conditioned supernatants were measured by ELISA, according to the recommended protocol (Duoset^®^, R&D Systems). Controls were composed of the non-stimulated cells and media alone.

Real-time PCR analysis
----------------------

At the end of each infection period for both infection models, total RNA was extracted from HPBCs by using the MasterPure™ RNA Purification Kit (Epicentre^®^ Biotechnologies) in accordance with the manufacturer\'s instructions. RNA quantity and purity of the samples were assessed using a Nanodrop^®^ (Thermo Scientific). All sample OD~260~/OD~280~ ratios were between 1.95 and 2.05. Thereafter, RNA was reverse-transcribed into cDNA using a High-Capacity cDNA Reverse Transcription kit following the manufacturer\'s instructions (Applied Biosystems). The cDNA product was amplified by real-time PCR (Step One Plus^®^, Applied Biosystems) and the mRNA levels for osteogenic genes, inflammatory genes, and internal control *HPRT-1* were determined using the double strand-specific Power SYBR^®^ Green dye system (Applied Biosystems). Primer sequences of all genes were determined with the Universal Probe Library Assay Design Center (Roche Applied Science). Primer efficiency was also measured (Table [1](#T1){ref-type="table"}). Data analysis was performed with the Step One software v2.3 (Applied Biosystems). Results were calculated in accordance with the 2^−ΔΔCt^ method and are presented as fold ratios.

###### 

**Primer nucleotide sequence for each primer couple**.

  **Target gene**   **Sequences**                      
  ----------------- ---------------------------------- ---------------------------------
  *COL1A1*          5′-GGGATTCCCTGGACCTAAAG-3′         5′-GGAACACCTCGCTCTCCAG-3′
  *SPARC*           5′-TTCCCTGTACACTGGCAGTTC-3′        5′-AATGCTCCATGGGGATGA-3′
  *SPP1*            5′-GAGGGCTTGGTTGTCAGC-3′           5′-CAATTCTCATGGTAGTGAGTTTTCC-3′
  *IBSP*            5′-GAGGGCTTGGTTGTCAGC-3′           5′-CAATTCTCATGGTAGTGAGTTTTCC-3′
  *BGLAP*           5′-TGAGAGCCCTCACACTCCTC-3′         5′-ACCTTTGCTGGACTCTGCAC-3′
  *IL-1β*           5′-CTGTCCTGCGTGTTGAAAGA-3′         5′-TTGGGTAATTTTTGGGATCTACA-3′
  *IL-6*            5′-GGAACAAGCCAGAGCTGTG-3′          5′-GGCTGGCATTTGTGGTTGG-3′
  *TNF-α*           5′-CAGCCTCCTCTCCTTCTTGAT-3′        5′-GCCAGAGGGCTGATTAGAGA-3′
  *CCL2*            5′-AGTCTCTGCCGCCCTTCT-3′           5′-GTGACTGGGGCATTGATTG-3′
  *CXCL1*           5′-TCCTGCATCCCCCATAGTTA-3′         5′-CTTCAGGAACAGCCACCAGT-3′
  *CXCL8*           5′-AGACAGCAGAGCACACAAGC-3′         5′-CTCCTTGGCAAAACTGCAC-3′
  *RANKL*           5′-TGATTCATGTAGGAGAATTAAACAGG-3′   5′-GATGTGCTGTGATCCAACGA-3′
  *OPG*             5′-GAAGGGCGCTACCTTGAGAT-3′         5′-GCAAACTGTATTTCGCTCTGG-3′
  *HPRT-1*          5′-TGACCTTGATTTATTTTGCATACC-3′     5′-CGAGCAAGACGTTCAGTCCT-3′

Scanning electron microscopy (SEM)
----------------------------------

SEM was performed for acute infection. After 9 h of co-culture, samples were rinsed twice with DPBS and then fixed with 2.5% glutaraldehyde in DPBS for 1 h at room temperature. After graded ethanol dehydration the samples were immersed in HMDS for 5 min, air-dried at room temperature and sputtered with a thin gold--palladium film under a JEOL ion sputter JFC 1100 (JEOL). Cells were observed with a LaB6 electron microscope (JEOL JSM-5400 LV).

Graphical representation of data and statistics
-----------------------------------------------

Each experiment was performed on cells from 4 of 11 independent donors. Each pool of cells consisted of cells grown in both SM and OM. Data are presented as whisker plots: black spots represent maximum and minimum values, black bars represent 1st and 9th decile, the bottom and top of the box are the 1st and 3rd quartiles, and the red band inside the box stands for the median. Gray box plots were used for HPBCs cultured in SM (SM-HPBCs) and black box plots were used for HPBCs cultured in OM (OM-HPBCs). Owing to a lack of normal distribution of the assessed variables due to the small number of donors, non-parametric exact Wilcoxon-Mann-Whitney tests with the *p*-value fixed at 0.05 were carried out to determine the significance of the results (StatXact 7.0, Cytel Inc.).

Results {#s3}
=======

Cell maturation is effective even without dexamethasone
-------------------------------------------------------

To investigate whether maturation may impact the behavior of HPBCs during *S. aureus* interaction, two populations of HPBCs at different stages of maturation were established. Maturation of osteoblasts is commonly performed by using OM containing dexamethasone. However, the anti-inflammatory molecule dexamethasone impacts cell signaling and would interfere in the readout of the studied mediators in our experiments. Therefore, specific osteoblast markers were assessed on both HPBCs population during their culture to assess the effectiveness of dexamethasone-free OM to promote osteoblastic maturation as compared to SM (Figure [1](#F1){ref-type="fig"}).

![**Osteogenic differentiation (A--D). (A)** Representative photographs of alkaline phosphatase staining of SM- and OM-HPBCs after 7, 14, 21, and 28 days of culture, **(B)** alizarin red staining of SM- and OM-HPBCs after 7, 14, 21, and 28 days of culture, and **(C)** expression of osteogenic genes by OM- compared to SM-HPBCs after 14 days of culture (mRNA were evaluated by RT-qPCR analysis, data were shown as specific variation in mRNA using the 2^−ΔΔCt^ method (*HPRT-1* was used as internal control), ^\*^ means *p* \< 0.05 vs. SM-HPBCs). **(D)** Representative micrographs of 21-day immunofluorescent staining of cultured cells: type I collagen and osteocalcin were visualized in green with Alexafluor^®^488. Nuclei were counterstained in blue by DAPI. Scale bar = 50 μm. Experiments were performed on four independent donors.](fcimb-06-00064-g0001){#F1}

Cells cultured in SM, hereafter named SM-HPBCs, presented a very low alkaline phosphatase activity and the alizarin red staining remained negative up to day 28 of culture (Figures [1A,B](#F1){ref-type="fig"}). Cells cultured in dexamethasone-free OM, hereafter named OM-HPBCs, exhibited a high alkaline phosphatase activity observed from day 14 to 28 as well as a positive alizarin red staining after day 28 of culture (Figures [1A,B](#F1){ref-type="fig"}). The mRNA expressions of five major bone extracellular matrix proteins were also analyzed to evaluate the commitment in osteogenic differentiation for both populations of V. As seen in Figure [1C](#F1){ref-type="fig"} after 14 days of culture, *COL1A1* expression was statistically lower for the OM-HPBCs compared to the expression by SM-HPBCs. No difference in *SPARC* and *SPP1* expressions could be seen. *IBSP* expression appeared upregulated and *BGLAP* was significantly increased in OM-HPBCs as compared to SM-HPBCs.

Immunofluorescence staining at day 21 confirmed the difference between the cultured cells (Figure [1D](#F1){ref-type="fig"}). Low production of type I collagen and absence of osteocalcin were observed for SM-HPBCs. On the contrary, type I collagen extracellular fibers as well as the presence of osteocalcin could be detected for OM-HPBCs.

These results suggested that at a given time, the culture of HPBCs in a dexamethasone-free OM promoted a higher production of specific mature osteoblast markers compared to HPBCs cultured in SM. Therefore, OM-HPBCs may be considered as more mature than SM-HPBCs.

*S. aureus* can survive inside HPBCs
------------------------------------

Acute and persistent infection models were used in order to investigate the impact of HPBC maturation on the internalization and the survival of *S. aureus* inside HPBCs. As seen in the acute infection model (Figure [2A](#F2){ref-type="fig"}), the average number of intracellular bacteria was under 120 bacteria per 1000 cells after 1 h of interaction, irrespective of the cell differentiation. This figure regularly increased with time up to 9 h. After 9 h of interaction, the average number of internalized live bacteria reached at least 8350 bacteria per 1000 cells.

![**Internalization (A) and survival of *S. aureus* (B) and effect of *S. aureus* on cell death (C,D)**. SM- (gray boxes) and OM-HPBCs (black boxes) were exposed to viable *S. aureus* (MOI of 10:1 and 30:1) for 1, 3, 6, and 9 h in acute infection **(A,C)** and for 1, 9, 24, and 48 h in persistent infection **(B,D)**. For internalization **(A)** and survival of *S. aureus* **(B)**, the number of intracellular bacteria was determined after serial plating. ¥ means *p* \< 0.05 compared to value at 1 h for the same MOI, \$ means *p* \< 0.05 compared to value at 3 h for the same MOI, \$ means *p* \< 0.05 compared to value at 6 h for the same MOI. For cell viability **(C,D)**, LDH activity was measured in cell supernatants. Data are shown as specific variation in optical density compared to optical density of relative non-infected cells. ^\*^ means *p* \< 0.05 compared to non-infected cells. Experiments were performed on four independent donors.](fcimb-06-00064-g0002){#F2}

In the persistent infection model (Figure [2B](#F2){ref-type="fig"}), the number of intracellular *S. aureus* seemed to decrease slightly from 1 to 48 h irrespective of the cell differentiation. Intracellular staphylococci survived inside the cells until 48 h with an average count between 10 and 45 bacteria per 1000 cells depending on the MOI. For each time, the number of bacteria was systematically higher with the MOI of 30:1 than with the MOI of 10:1.

Comparing both models at 9 h post infection, at least a 2 log reduction was observed in the number of intracellular bacteria in the cells after persistent infection as compared to acute infection (Figures [2A,B](#F2){ref-type="fig"}).

Similar results for internalization and survival of *S. aureus* were observed in both SM- and OM-HPBCs, suggesting that HPBC maturation did not influence these phenomena, though a difference in bacterial adhesion was observed between SM- and OM-HPBCs (Figure [3](#F3){ref-type="fig"}).

![**Representative SEM micrographs of interaction between *S. aureus* and SM- (A) or OM-HPBCs (B) after 9 h at the MOI of 10:1 in acute infection model**. Magnification x1000.](fcimb-06-00064-g0003){#F3}

Nevertheless, the ability of HPBCs to contain viable intracellular bacteria was strongly influenced by the presence of extracellular bacteria.

*S. aureus* induces cell death
------------------------------

To determine whether cell maturation influences *S. aureus*-induced cell death, we measured the release of LDH from both SM and OM-HPBCs. In the acute infection model, a low but significant decrease in LDH activity was observed at 1 h for SM-HPBCs. After 6 h of interaction, significant increases in LDH activity were detected in the presence of *S. aureus* at the MOIs of 10:1 or 30:1 for both SM and OM-HPBCs (Figure [2C](#F2){ref-type="fig"}). At 9 h post-infection a greater and significant LDH release was observed without any MOI effects (10:1 or 30:1).

As for the persistent infection model, the release of LDH was more variable between each time point, with the level of LDH sometimes even lower for the infected cells, like for OM-HPBCs at 1 and 9 h post-infection (Figure [2D](#F2){ref-type="fig"}). Apart from that, the quantity of LDH released by both populations of HPBCs was statistically similar in the presence of *S. aureus* from 1 to 48 h.

Similar results were observed for both SM- and OM-HPBCs, suggesting that HPBC maturation has no influence in the protection against cell death caused by *S. aureus*. However, the accumulation of extracellular *S. aureus* increased cell death in the acute infection model.

*S. aureus*-related production of pro-inflammatory cytokines by HPBCs
---------------------------------------------------------------------

The pro-inflammatory cytokines IL-1β, IL-6, and TNF-α are potent activators of osteoclastogenesis. Their presence in the bone microenvironment promotes inflammatory processes and the recruitment of pre-osteoclasts and their activation. To further characterize the impact of *S. aureus* on SM- and OM-HPBCs, the expression of these cytokines was analyzed.

In the acute infection model, *S. aureus* induced an increase in *IL-6* expression by SM-HPBCs that started at 6 h. At 9 h post-infection, this overexpression in infected cells corresponded to a 2.7-fold increase for the MOI of 10:1 and a 3.9-fold increase for the MOI of 30:1. For OM-HPBCs, *S. aureus* also induced significant increases in *IL-6* expression at 3 h with an average of 1.5-fold for both MOIs. At 9 h post-infection a two-fold overexpression for the MOI of 10:1 and of 2.5-fold for the MOI of 30:1 were observed (Figure [4A](#F4){ref-type="fig"}). No significant variations were observed for *IL-1β* and *TNF-α* expression in the acute infection model even if a trend for increase was observed for both the cytokines mRNAs in the presence of *S. aureus* after 9 h (Figures [4C,E](#F4){ref-type="fig"}).

![**Effect of *S. aureus* on *IL-6* (A,B), *IL-1β* (C,D), and *TNF-α* (E,F) mRNA expressions by SM- (gray boxes) and OM-HPBCs (black boxes)**. Cells were exposed to viable *S. aureus* (MOI of 10:1 and 30:1) for 1, 3, 6, and 9 h in acute infection **(A,C,E)** and for 1, 9, 24, and 48 h in persistent infection **(B,D,F)**. Expression of *IL-6, IL-1β*, and *TNF-α* mRNA was evaluated by RT-qPCR analysis. Data are shown as specific variation of mRNA compared to relative non-infected cells using the 2^−ΔΔCt^ method (*HPRT-1* was used as internal control). ^\*^ means *p* \< 0.05 vs. relative non-infected cells for each time period. Experiments were performed on four independent donors.](fcimb-06-00064-g0004){#F4}

Of note, *IL-1β*, *IL-6*, and *TNF-α* expressions were up-regulated from 3 to 9 h by both SM and OM-HPBCs stimulated with LPS (Supplementary Figures [1A,C,E](#SM1){ref-type="supplementary-material"}).

In the persistent infection model, a low but significant 1.2-fold increase in *IL-6* mRNA expression was observed for infected SM-HPBCs after 48 h of interaction at both 10:1 and 30:1 MOIs. The same profile was seen with OM-HPBCs, with a significant 1.9-fold increase for the MOI of 30:1 (Figure [4B](#F4){ref-type="fig"}). Concerning *IL-1β*, *S. aureus* induced a significant 1.7-fold increase in mRNA expression in OM-HPBCs after 48 h of infection (Figure [4D](#F4){ref-type="fig"}). No significant variations in *TNF-α* expression were observed in the model of persistent infection (Figure [4F](#F4){ref-type="fig"}).

Of note, *IL-1β* and *IL-6* expressions were up-regulated in both SM- and OM-HPBCs stimulated with LPS until 48 h whereas *TNF-α* expression only increased at 1 and 9 h (Supplementary Figures [1B,D,F](#SM1){ref-type="supplementary-material"}).

To further investigate the protein release that could correlate with the significant mRNA expression modulations, IL-6 and IL-1β protein release was measured. Concerning IL-6 (Table [2](#T2){ref-type="table"}), the protein release was detected in supernatants of the cells of all donors after 3 h in the acute model of infection and after 9 h in the persistent infection one. Thereafter, the release of IL-6 by both cell types increased regularly in both acute and persistent infection models and remained within the levels of the non-infected control HPBCs. However, LPS stimulation induced an upregulation of IL-6 when compared to the control cells (Supplementary Table [1](#SM1){ref-type="supplementary-material"}). No protein release of IL-1β by HPBCs was detected regardless of the model of infection, even after stimulation with LPS (data not shown).

###### 

**Effect of *S. aureus* on IL-6 protein release by SM-HPBCs (white columns) and OM-HPBCs (gray columns)**.

  **Acute infection**                                                                                                                                                                                                                         
  -------------------------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------
  **IL-6**                   **1 h**    **3 h**    **6 h**    **9 h**                                                                                                                                                                         
  **pg.mL**−1                **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**                                                                                
  Max                        97         209        97         136        75         119        429        442        397        317        375        337        702    604    560    498    647    630    927    924    892    893    894    843
  Median                     22         5          14         12         15         7          99         73         72         61         111        57         254    153    328    231    347    242    671    717    671    718    667    702
  Min                        --         --         --         --         --         --         14         29         31         18         30         19         113    120    105    94     173    78     471    571    442    527    419    459
  **Persistent infection**                                                                                                                                                                                                                    
  **IL-6**                   **1 h**    **9 h**    **24 h**   **48 h**                                                                                                                                                                        
  **pg.mL**−1                **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**                                                                                
  Max                        2097       1947       1688       2136       1983       1939       3324       3242       2670       3212       3250       3152       4523   4852   3943   5095   4778   5023   5011   6250   4284   5773   4778   6155
  Median                     726        895        714        781        683        750        2445       2540       1682       2409       1918       2213       3712   3422   3068   3047   3315   3047   3939   4066   3170   3739   3358   3630
  Min                        24         --         105        17         --         --         583        82         521        73         424        54         779    85     738    121    612    82     833    94     750    119    810    114

*Cells were exposed to viable S. aureus (MOI of 10:1 and 30:1) for 1, 3, 6, and 9 h in acute infection and for 1, 9, 24, and 48 h in persistent infection. Data are presented as minimal value, median value, and maximal value from four independent donors (-- means undetermined)*.

In summary, *S. aureus* induced low but statistically significant increases in mRNA expression of IL-6 in both SM- and OM-HPBCs and a small increase in IL-1β mRNA at 48 h post-infection in OM-HPBCs. These results suggest that HPBC maturation did not influence cytokine expression. In our infection models, we also found that the relative protein release by SM- and OM-HPBCs was not influenced by the presence of *S. aureus* even if cells of all our donors were responsive to LPS stimulation.

*S. aureus*-related production of chemokines by HPBCs
-----------------------------------------------------

Chemokines are well known for playing a role in antibacterial defense notably through the recruitment of neutrophils and monocytes/macrophages. To further investigate how HPBC maturation modulates the inflammatory response of infected cells, the expression and the release of CCL2, CXCL1, and CXCL8 by SM- and OM-HPBCs infected with *S. aureus* was evaluated.

In acute infection, no variation in *CCL2* mRNA expression was measured for infected SM-HPBCs compared to their non-infected counterparts. For infected OM-HPBCs, a significant two-fold decrease in *CCL2* expression was observed at MOIs of 10:1 and 30:1 after 9 h (Figure [5A](#F5){ref-type="fig"}). Focusing on *CXCL1* expression (Figure [5C](#F5){ref-type="fig"}), at 6 h post-infection a 4.5-fold increase in *CXCL1* expression was observed for SM-HPBCs at the MOI 10:1 as well as a 12.3-fold increase for MOI 30:1. At 9 h post infection, the expression was decreased but still in the upper range as compared to the basal expression by uninfected SM-HPBCs. Levels of *CXCL1* mRNA appeared higher for infected cells at 6 h than in the uninfected cells though there were no significant differences for OM-HPBCs (Figure [5C](#F5){ref-type="fig"}). For *CXCL8*, SM-HPBCs interacting with *S. aureus* exhibited significant increases in mRNA expression (Figure [5E](#F5){ref-type="fig"}). At 6 h, a significant four-fold mean increase was observed for the MOI of 30:1. At 9 h, *S. aureus* significantly upregulated the mean expression of *CXCL8* by 4.2-fold and 5.9-fold for the MOIs of 10:1 and 30:1, respectively. For OM-HPBCs, *S. aureus* did not significantly impact *CXCL8* expression. Nevertheless, a trend for an increase was observed after 9 h interaction between OM-HPBCs and *S. aureus* (Figure [5E](#F5){ref-type="fig"}).

![**Effect of *S. aureus* on *CCL2* (A,B), *CXCL1* (C,D), and *CXCL8* (E,F) mRNAs expressions by SM- (gray boxes) and OM-HPBCs (black boxes)**. Cells were exposed to viable *S. aureus* (MOI of 10:1 and 30:1) for 1, 3, 6, and 9 h in acute infection **(A,C,E)** and for 1, 9, 24, and 48 h in persistent infection **(B,D,F)**. Expressions of *CCL2, CXCL1*, and *CXCL8* mRNA were evaluated by RT-qPCR analysis. Data are shown as specific variation in mRNA compared to relative non-infected cells using the 2^−ΔΔCt^ method (*HPRT-1* was used as internal control). ^\*^ means *p* \< 0.05 vs. relative non-infected cells for each time period. Experiments were performed on four independent donors.](fcimb-06-00064-g0005){#F5}

Of note, *CCL2, CXCL1*, and *CXCL8* expression was up-regulated by both SM and OM-HPBCs from 3 to 9 h after stimulation with LPS (Supplementary Figures [2A,C,E](#SM1){ref-type="supplementary-material"}).

In the persistent infection model, no significant variations in *CCL2* by SM-HPBCs were observed (Figure [5B](#F5){ref-type="fig"}). Conversely OM-HPBCs showed low but significant increases in *CCL2* expression at both 24 h and 48 h. A 1.2-fold mean increase was observed for both MOIs of 10:1 and 30:1 at 24 h. At 48 h, *S. aureus*-induced mean increases of 1.2-fold and 1.6-fold for the MOIs of 10:1 and 30:1 respectively (Figure [5B](#F5){ref-type="fig"}). Concerning *CXCL1* expression, no significant variations were observed for SM-HPBCs (Figure [5D](#F5){ref-type="fig"}). For OM-HPBCs, a significant mean increase in *CXCL1* expression by 2.1-fold was observed at 48 h for the MOI of 30:1 (Figure [4D](#F4){ref-type="fig"}). For *CXCL8* expression, slight increases were detected after 48 h in the presence of *S. aureus* with a significant 3.6-fold mean increase in SM-HPBCs infected at the MOI of 30:1 (Figure [5F](#F5){ref-type="fig"}). *CCL2, CXCL1*, and *CXCL8* expressions were up-regulated by both SM and OM-HPBCs stimulated with LPS until 48 h (Supplementary Figures [2B,D,F](#SM1){ref-type="supplementary-material"}).

To further investigate the impact of *S. aureus* on HPBCs, the protein release of the three previously studied chemokines was measured.

In the acute infection model (Table [3](#T3){ref-type="table"}), CCL2 and CXCL8 protein releases were detected in supernatants of the cells of all donors only after 9 h and were within the levels of the non-infected control HPBCs.

###### 

**Effect of *S. aureus* on CCL2, CXCL1, and CXCL8 protein release by SM-HPBCs (white columns) and OM-HPBCs (gray columns)**.

  **Acute infection**                                                                                                                                                                                                                                                       
  -------------------------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- ---------- ------ ---------- ------ ---------- -------- ---------- -------- ---------- --------
  **CCL2**                   **1 h**    **3 h**    **6 h**    **9 h**                                                                                                                                                                                                       
  **pg.mL**−1                **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**                                                                                                              
  Max                        573        1259       355        1105       405        1005       1232       2341       950        2291       665        2668       5123       8059     5609       8027   6900       7695   5877       7538     5375       5641     5142       8082
  Median                     --         306        --         189        --         --         --         589        --         623        --         639        407        704      589        791    809        942    3870       3310     2272       4754     1806       4443
  Min                        --         --         --         --         --         --         --         --         --         --         --         --         --         --       --         --     --         --     426        2444     593        1060     523        1000
  **Persistent infection**                                                                                                                                                                                                                                                  
  **CCL2**                   **1 h**    **9 h**    **24 h**   **48 h**                                                                                                                                                                                                      
  **pg.mL**−1                **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**                                                                                                              
  Max                        2294       1792       2188       2133       1775       1871       6525       6037       3325       5926       3738       6532       9500       10,329   8381       9352   9331       9912   13,756     11,458   11,494     11,356   12,889     11,389
  Median                     674        1473       556        1474       640        1465       2722       4955       2640       4999       2855       4935       6007       7154     5314       7368   5115       7487   9324       7040     7296       8226     10,915     8274
  Min                        --         --         --         --         --         --         1983       4102       1539       4242       2083       3942       2761       6019     2517       5989   2722       6027   2928       2008     3261       1742     4549       7633
  **Acute infection**                                                                                                                                                                                                                                                       
  **CXCL1**                  **1 h**    **3 h**    **6 h**    **9 h**                                                                                                                                                                                                       
  **pg.mL**−1                **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**                                                                                                              
  Max                        --         218        220        --         224        --         222        --         238        --         238        --         216        214      260        211    218        211    --         317      275        361      269        807
  Median                     --         --         --         --         --         --         --         --         --         --         --         --         --         198      --         97     --         99     --         259      93         286      90         273
  Min                        --         --         --         --         --         --         --         --         --         --         --         --         --         --       --         --     --         --     --         --       --         --       --         --
  **Persistent infection**                                                                                                                                                                                                                                                  
  **CXCL1**                  **1 h**    **9 h**    **24 h**   **48 h**                                                                                                                                                                                                      
  **pg.mL**−1                **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**                                                                                                              
  Max                        --         --         --         --         --         --         271        291        --         346        --         373        228        413      230        406    285        377    262        517      278        670      287        555
  Median                     --         --         --         --         --         --         93         92         --         97         --         98         --         110      --         106    119        102    --         149      --         121      --         132
  Min                        --         --         --         --         --         --         --         --         --         --         --         --         --         --       --         --     --         --     --         --       --         --       --         --
  **Acute infection**                                                                                                                                                                                                                                                       
  **CXCL8**                  **1 h**    **3 h**    **6 h**    **9 h**                                                                                                                                                                                                       
  **pg.mL**−1                **Ctrl**              **10:1**              **30:1**              **Ctrl**              **10:1**              **30:1**              **Ctrl**            **10:1**          **30:1**          **Ctrl**            **10:1**            **30:1**   
  Max                        --         --         --         --         --         --         46         --         41         --         44         --         45         220      258        530    353        528    415        707      413        690      410        687
  Median                     --         --         --         --         --         --         --         --         --         --         --         --         --         38       --         33     --         29     212        370      215        372      186        357
  Min                        --         --         --         --         --         --         --         --         --         --         --         --         --         --       --         --     --         --     --         27       35         37       32         31
  **Persistent infection**                                                                                                                                                                                                                                                  
  **CXCL8**                  **1 h**    **9 h**    **24 h**   **48 h**                                                                                                                                                                                                      
  **pg.mL**−1                **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**                                                                                                              
  Max                        198        262        191        240        192        236        651        461        498        470        573        457        678        521      637        481    782        496    718        570      633        551      674        613
  Median                     79         94         66         83         84         93         443        387        408        354        386        350        524        436      541        404    529        417    566        472      597        466      627        538
  Min                        --         --         --         --         --         --         --         51         --         52         --         64         27         213      --         195    --         197    50         270      35         300      53         385

*Cells were exposed to viable S. aureus (MOI of 10:1 and 30:1) for 1, 3, 6, and 9 h in acute infection and for 1, 9, 24, and 48 h in persistent infection. Data are presented as minimal value, median value, and maximal value from four independent donors (-- means undetermined)*.

In the persistent model of infection (Table [3](#T3){ref-type="table"}), the release of CCL2 by the HPBCs of all donors increased with time from 9 to 48 h and was within the levels of the non-infected HPBCs. Concerning CXCL8, the protein release was detected in supernatants of OM-HPBCs of all donors from 9 to 48 h and stayed within the levels of the non-infected control OM-HPBCs whereas it only occurred at 48 h for SM-HPBCs.

No *CXCL1* protein release was detected in the supernatants of the cells of any of the donors at the same time in both the acute and persistent infection models (Table [3](#T3){ref-type="table"}). LPS stimulation nevertheless induced up-regulation of all the three chemokines when compared to the control cells in both models of infection (Supplementary Table [2](#SM1){ref-type="supplementary-material"}).

Taken together, these results revealed that the infected SM-HPBCs are more able to upregulate their chemokine expression compared to the infected OM-HPBCs in the conditions of acute infection, suggesting an impact of HPBC maturation. However, we also found that the relative protein release by both SM- and OM-HPBCs was not influenced by the presence of *S. aureus* even if the cells of all our donors were responsive to LPS stimulation.

*S. aureus*-related production of OPG and RANKL by HPBCs
--------------------------------------------------------

Bone-forming cells can modulate osteoclastogenesis through the production of RANKL and OPG. RANKL binds to RANK on osteoclast precursors to promote their activation whereas OPG is a decoy receptor for RANKL that can decrease osteoclastogenesis. The impact of osteogenic differentiation and *S. aureus* interaction on *OPG* and *RANKL* expression was therefore evaluated (Figure [6](#F6){ref-type="fig"}).

![**Effect of *S. aureus* on *OPG* (A,B) and *RANKL* (C,D) mRNAs expressions by SM- (gray boxes) and OM-HPBCs (black boxes)**. Cells were exposed to viable *S. aureus* (MOI of 10:1 and 30:1) for 1, 3, 6, and 9 h in acute infection **(A,C)** and for 1, 9, 24, and 48 h in persistent infection **(B,D)**. Expressions of *OPG* and *RANKL* mRNA were evaluated by RT-qPCR analysis. Data are shown as specific variation of mRNA compared to relative non-infected cells using the 2^−ΔΔCt^ method (*HPRT-1* was used as internal control). ^\*^ means *p* \< 0.05 vs. relative non-infected cells for each time period. Experiments were performed on four independent donors.](fcimb-06-00064-g0006){#F6}

In the acute infection model, for both SM- and OM-HPBCs, 9 h were required to observe a two-fold mean significant decrease in *OPG* expression for both 10:1 and 30:1 MOIs (Figure [6A](#F6){ref-type="fig"}). Conversely LPS stimulation induced a significant increase in *OPG* expression at 6 and 9 h with both HPBCs (Supplementary Figure [3A](#SM1){ref-type="supplementary-material"}).

In the persistent infection model, the level of *OPG* mRNA remained equal in the presence or absence of bacteria for both HPBCs up to 48 h whereas an increase in expression was observed from 9 to 48 h when both the HPBCs were stimulated with LPS (Figure [6B](#F6){ref-type="fig"}, Supplementary Figure [3B](#SM1){ref-type="supplementary-material"}). Concerning RANKL, no significant modulation of expression was observed in any condition even with LPS stimulation (Figures [6C,D](#F6){ref-type="fig"}, Supplementary Figures [3C,D](#SM1){ref-type="supplementary-material"}).

To further investigate the impact of *S. aureus* on HPBCs, the protein release of OPG was measured in cell supernatants. In the acute infection model (Table [4](#T4){ref-type="table"}), OPG protein release was detected in supernatants of the cells of all donors from 6 to 9 h and was within the levels of the non-infected control HPBCs. On the whole, the release by all the cells increased from 1 to 6 h and decreased at 9 h. In the persistent model of infection (Table [4](#T4){ref-type="table"}), OPG protein release by the cells of all donors increased with time from 9 to 48 h and was within the levels of the non-infected HPBCs. LPS stimulation, however, induced up-regulation of OPG when compared to the control cells in both models of infection (Supplementary Table [3](#SM1){ref-type="supplementary-material"}).

###### 

**Effect of *S. aureus* on OPG protein release by SM-HPBCs (white columns) and OM-HPBCs (gray columns)**.

  **Acute infection**                                                                                                                                                                                                                                               
  -------------------------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- --------
  **OPG**                    **1 h**    **3 h**    **6 h**    **9 h**                                                                                                                                                                                               
  **pg.mL**−1                **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**                                                                                                      
  Max                        1705       2327       1639       3891       2053       3836       4933       8545       5813       6255       4800       8873       12,909   19,891   15,738   7227     12,773   17,636   16,133   22,065   15,147   18,370   15,413   23,043
  Median                     1308       1165       1128       1335       1181       1086       3365       3039       4646       2346       3268       3984       10,521   5634     10,817   6306     11,630   6654     4470     6162     5536     6401     5324     7288
  Min                        --         130        --         --         --         --         1000       826        1739       1522       --         2043       3565     3348     6391     4826     3565     5410     1443     3377     1902     5273     3475     4273
  **Persistent infection**                                                                                                                                                                                                                                          
  **OPG**                    **1 h**    **9 h**    **24 h**   **48 h**                                                                                                                                                                                              
  **pg.mL**−1                **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**   **Ctrl**   **10:1**   **30:1**                                                                                                      
  Max                        6719       6896       10,656     4938       9469       5688       17,469     12,646     10,625     10,902     11,844     9699       27,219   25,000   25,781   23,788   31,156   30,455   39,819   87,355   72,250   65,072   49,781   83,949
  Median                     1330       2346       1178       2529       1339       2539       4305       6915       6081       7108       5233       7253       11,548   13,958   12,679   16,361   13,515   18,292   21,231   33,149   26,050   27,990   24,734   30,538
  Min                        700        --         683        --         667        --         1834       155        2125       --         2334       --         4521     310      4979     143      4938     393      7875     1274     7021     1298     7083     1417

*Cells were exposed to viable S. aureus (MOI of 10:1 and 30:1) for 1, 3, 6, and 9 h in acute infection and for 1, 9, 24, and 48 h in persistent infection. Data are presented as minimal value, median value, and maximal value from four independent donors (-- means undetermined)*.

To summarize, in the acute infection model, *S. aureus* induced a similar decrease in *OPG* mRNA expression in both SM- and OM-HPBCs, suggesting that HPBC maturation is not involved in such an effect. In our infection models, we also found that the OPG protein release by SM- and OM-HPBCs was not influenced by the presence of *S. aureus*, even if the cells of all our donors were responsive to LPS stimulation.

Discussion {#s4}
==========

The bone microenvironment is a complex environment where osteoblasts and their precursors play a central role. Originating from the mesenchymal lineage, osteoblasts are the cells responsible for bone formation. Differentiation of bone-forming cells starts from mesenchymal stem cells, evolves through several states such as osteoprogenitors, pre-osteoblasts, and osteoblasts and ends up as matrix-embedded cells known as osteocytes (Aubin, [@B3]). Osteoblasts are the major cells for the synthesis of the bone organic matrix. The latter is mostly composed of type I collagen but also contains non-collagenous proteins such as fibronectin, osteopontin, and osteocalcin (Marie, [@B26]). Up to now, the conditioning culture media for osteoblast maturation *in vitro* was composed of ascorbic acid, β-glycerophosphate, and dexamethasone to trigger bone matrix mineralization (Park, [@B32]; Langenbach and Handschel, [@B21]). Here, for the first time to our knowledge, the maturation of bone cells with high alkaline phosphatase activity increased type I collagen fiber formation and the release of osseous proteins such as osteocalcin was obtained with a dexamethasone-free OM. Using both non-osteogenic and dexamethasone-free osteogenic media, we were able to establish two cell populations at different stages of maturation from the same patient, a step that is very important for assessing the effects of maturation on cell physiology without any genetic side effects. This is an important prerequisite as the impact of osteoblast maturation on *S. aureus* infection has not been taken into account to date. Furthermore, being able to obtain this maturation without the use of dexamethasone avoids its interference with the inflammatory response of HPBCs (Wright and Friedland, [@B44]), which is of great importance for the parameters studied in this paper.

Interaction between *S. aureus* and osteoblasts began to be documented with the demonstration of internalization by Hudson and colleagues. Then more recent studies highlighted the involvement of staphylococcal toxins and small colony variants during osteoblast infection (Hudson et al., [@B14]; Tuchscherr et al., [@B36]; Valour et al., [@B41]). Most of these studies that used live *S. aureus* focused on the persistent interaction with murine or human osteoblast cell lines, so the onset of infection and the consequences of extracellular growing bacteria were rarely considered except by Hamza and Li ([@B13]).

Therefore, to document more precisely the effect of the degree of maturation of human osteoblasts on cell responses toward *S. aureus*, we used two different *in vitro* models of infection. The first one---the acute infection model---which allows direct interaction from 1 to 9 h between live *S. aureus* and HPBCs, was previously used to test the interaction of *S. aureus* with mesenchymal stem cells (Josse et al., [@B18]). This model examines the impact of both intracellular and extracellular staphylococci growing in the osteoblast environment. The second one---the persistent infection model---was adapted from a pre-existent *in vitro* model (Wright and Friedland, [@B43]), where extracellular staphylococci are specifically killed by gentamycin after 1 h of interaction in order to preserve only intracellular bacteria until 48 h.

Since infection of osteoblasts by *S. aureus* is a landmark in the development of osteomyelitis in bone tissue, we looked at various parameters that are associated with bacterial pathogenesis, such as attachment, internalization, bacterial survival, and the capacity to induce pro-inflammatory cytokines or chemokines that play a major role in the stimulation of other cells in the bone microenvironment. *S. aureus* NCTC 8325-4, a commonly used laboratory bacterium, was used to check whether the maturation of HPBCs can have an impact on its pathogenesis toward HPBCs and whether it can stimulate HPBCs as in previous early interaction cell models (Escotte et al., [@B12]; Al Alam et al., [@B2]).

Attachment is the first step in the bacterial infection process. SEM preparations of interactions of *S. aureus* on SM- and OM-HPBCs showed that *S. aureus* can bind to both types of cells with a greater susceptibility for OM-HPBCs, which could be due to a greater presence of extracellular matrix proteins around these HPBCs.

As seen previously by others, internalization is the prerequisite for the putative survival of *S. aureus* inside osteoblasts (Hudson et al., [@B14]; Tuchscherr and Löffler, [@B37]) and *S. aureus* collagen adhesion (Cna) and bone sialoprotein binding protein (Bbp) could play a synergistic role in the initial adhesion of *S. aureus* to osteoblasts, thereby promoting fibronectin-mediated internalization (Tung et al., [@B39]; Ahmed et al., [@B1]; Testoni et al., [@B35]). Comparing both models after 9 h of infection, it is nevertheless clear that extracellular bacteria were constantly internalized by the HPBCs, thus explaining why the intracellular pool is larger in the acute infection model than in the persistent one.

Furthermore, even if in our hands OM-HPBCs showed a higher expression of bone sialoprotein gene (*IBSP*) and a higher production of type I collagen fibers, no differences in internalization and survival of *S. aureus* inside SM- and OM-HPBCs could be seen, suggesting that *S. aureus* also uses mechanisms of internalization to invade HPBCs that are independent from the bone extracellular matrix.

Bone loss in osteomyelitis is due to the death of osteoblasts, a phenomenon that is itself potentiated by the increased activation of osteoclasts. A tight balance between bone formation by osteoblasts and bone resorption by osteoclasts is essential for the strength and integrity of bones. Therefore, we monitored the death of HPBCs after *S. aureus* infection, as well as the production of osteoclastic regulators.

Internalization of *S. aureus* is a key event in the induction of cell death through apoptosis (Bayles et al., [@B4]; Menzies and Kourteva, [@B29]; Kahl et al., [@B19]; Mempel et al., [@B28]). Here, as in a previous experiment with mesenchymal stem cells (Josse et al., [@B18]), cell death was observed after 6 h of acute infection, irrespective of HPBC maturation. Although Rasigade et al. recently reported that the activity of phenol-soluble modulins is the major factor in osteoblast killing by *S. aureus* and that α-hemolysin activity is negligible (Rasigade et al., [@B33]), the α-hemolysin produced by the extracellular *S. aureus* NCTC 8325-4 could play a role in the death phenomenon in acute infections, as no differences were noted in the persistent model where the bacteria were only intracellular.

Following interaction with *S. aureus*, the first line of defense for cells is to secrete inflammatory factors like cytokines or chemokines, which are able to activate and recruit immune cells in an attempt to clear the bacteria from the microenvironment (Turner et al., [@B40]).

For the first time, our study proposes a different kinetic of mRNA chemokine expression between infected SM- and OM-HPBCs as well as different profiles of expression in both the acute and persistent models.

In the acute infection model, *IL-6* mRNA over-expression by both SM- and OM-HPBCs infected with *S. aureus*, as well as the weak responses in *IL-1β* and *TNF-α* mRNA expressions, were already observed during *S. aureus* and mesenchymal stem cell interaction (Josse et al., [@B18]). In the persistent infection model, *IL-6* and *IL-1β* mRNA expression was increased after 48 h, as observed in *in vitro* models similar to ours (Bost et al., [@B6]; Marriott et al., [@B27]; Jauregui et al., [@B16]). Our results also suggest that cell maturation does not impact cytokine expression.

With regard to chemokines, while *CCL2* mRNA is significantly downregulated in the acute infection of OM-HPBCs after 9 h, it does not vary in SM-HPBCs. Moreover, concerning *CXCL1* and *CXCL8* mRNA expression, it is obvious that the SM-HPBCs are more susceptible to *S. aureus* than the OM-HPBCs in the acute model of infection. On the contrary, no difference in susceptibility was noted in the persistent infection model. *CCL2* and *CXCL1* mRNA expression was upregulated by OM-HPBCs after 24 and 48 h respectively whereas a significant over-expression of *CXCL8* mRNA by SM-HPBCs was observed after 48 h. Moreover, these responses were *S. aureus*-specific as LPS induced the same chemokine profiles on both SM-HPBCs and OM-HPBCs in our models. One explanation could be that immature SM-HPBCs are more susceptible to inducing acute inflammation and to recruiting neutrophils in response to extracellular *S. aureus* while OM-HPBCs, which are more involved in matrix formation and mineralization, might be involved in subsequent inflammation and could potentially recruit monocytes in response to intracellular bacteria. Furthermore, while *CCL2* and *CXCL8* mRNA expression increased by *S. aureus*-infected osteoblasts has already been observed in an *in vitro* model close to our model of persistent infection (Bost et al., [@B5]; Jauregui et al., [@B16]), this is the first time, to our knowledge, that an over-expression of *CXCL1* mRNA has been observed in *S. aureus*-infected HPBCs.

Bone-forming cells influence osteoclastogenesis through the production of RANKL and its decoy receptor OPG. OPG inhibits RANK/RANKL binding and thereby modulates the formation and activation of osteoclasts (Edwards and Mundy, [@B11]). In our persistent infection model, neither the expression of *RANKL* nor *OPG* mRNA varied, even in the presence of *S. aureus*. However, for the first time and in opposition to the increase in *OPG* expression after LPS stimulation, a decrease in *OPG* expression without any modulation of *RANKL* for either SM- or OM-HPBCs was noticed after 9 h in the acute infection model. This suggests that the regulation of *OPG* could be induced specifically by *S. aureus* and that extracellular bacteria could play a major role in the regulation.

Concerning the protein release of cytokines and chemokines, we did not observe any significant variations in the release by *S. aureus*-infected HPBCs compared to the non-infected counterparts whereas the upregulation of IL-6, CCL2, CXCL1, CXCL8, and OPG release occurred with LPS stimulation in both SM- and OM-HPBCs. These results are in opposition to early experiments where upregulation of IL-6, CCL2, and CXCL8 release was reported (Bost et al., [@B6], [@B5]; Wright and Friedland, [@B43]; Jauregui et al., [@B16]) as well as a decrease in OPG release (Claro et al., [@B10]; Young et al., [@B45]). These differences could be due to conditions of the experimental procedures, notably the characteristics of the cells. In previous studies, *in vitro* experiments were mostly performed using osteoblastic cell lines or marketed normal osteoblasts coupled with high MOIs (75:1 or 250:1) to stimulate the cells. This may have led to an overestimation of the results. In our study, we used human primary cells from several independent donors. This certainly contributed to the wide inter-donor viability that we observed but it also strengthens our results with regard to the clinical outcome in patients.

In view of our findings, we suggest that osteoblasts are not the initiators of an inflammatory response but act more as reservoirs allowing the persistence of *S. aureus* inside bones and the development of chronic infections. Recent findings about small colony variants, staphylococcal toxin-related osteoblast killing, or the adaptation of *S. aureus* to chronicity provide further evidence for this hypothesis (Valour et al., [@B41]; Tuchscherr and Löffler, [@B37]; Tuchscherr et al., [@B38]).

Conclusion {#s5}
==========

In this study, two models of *in vitro* interaction between *S. aureus* and HPBCs were established to investigate the impact of their maturation on osteomyelitis. HPBC maturation did not influence the internalization and survival of *S. aureus* inside HPBCs nor the cell death related to the infection. Furthermore, it had little impact on chemokine expression. Nevertheless, no variation in relative protein release was observed in the presence of *S. aureus*, suggesting the absence of any concrete inflammatory response by infected HPBCs. Our findings suggest that cell maturation does not impact the behavior of HPBCs infected with *S. aureus* and that the role of bone-forming cells (including osteoblasts) may not be pivotal for the inflammatory response in osteomyelitis.
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